Link: https://links.sgx.com/1.0.0/corporate-announcements/UWCIVSMQ9XJOMHKU/9ef8c0977ee8ebbe803c02d480d6b7d93fe5e4300cddd1bf7e23dcfca58721a2

Summary:

• Tianjin Pharmaceutical Da Ren Tang Group has completed the sale of its remaining 12% equity stake in Tianjin TSKF Pharmaceutical Co., Ltd.

• The stake was sold to Haleon China Co., Ltd. and Haleon CH SARL for a total consideration of RMB1.62 billion.

• Industrial and commercial registration formalities for the disposal have been completed.

• Following this transaction, the company no longer holds any equity in Tianjin TSKF.

• The disposal was approved by shareholders at the EGM on 9 June 2025.